CervoMed Inc

NASDAQ:CRVO   4:00:00 PM EDT
6.29
+0.24 (+3.88%)
: $6.00 -0.29 (-4.54%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)56.82M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.44 Million
Adjusted EPS-$0.59
See more estimates
10-Day MA$6.67
50-Day MA$8.12
200-Day MA$8.03
See more pivots

CervoMed Inc Stock, NASDAQ:CRVO

20 Park Plaza, Suite 424, Boston, Massachusetts 02216
United States of America
Phone: +1.617.744.4400
Number of Employees: 15

Description

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.